Clinical work showed that patients with recurrent CML and AML treated with a combination of donor lymphocyte transfusions with pre-emptive administration of GM-CSF and IFN-α2 reached long-term remissions, indicating the beneficial effect of cytokine stimulation of graft-versus-leukemia reactions. This evidence concerns the gene CSF2 and acute myeloid leukemia.